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We (7, 37, 38) have previously characterized a family of tail-anchored membrane proteins from the myocardium designated the sarcolemmal membrane-associated proteins (SLMAPs). Several SLMAP isoforms of varying molecular size (35, 45, 63 , and 83-91 kDa) were expressed in the myocardium as a result of alternative splicing of the 5=-region in the SLMAP gene (37, 38) . The short 35-kDa isoform (SLMAP1) was predominantly expressed in cardiac and slowtwitch skeletal muscle (7, 8, 37, 38) , while the 83-to 91-kDa isoform was ubiquitous. Analysis of the primary structure of SLMAP revealed an extended coiled-coil with a hydrophobic C-terminal sequence, which includes the transmembrane (TM) domain targeting subcellular membranes (1, 7, 37, 38) . All SLMAP isoforms contain a central leucine zipper (LZ) type coiled-coil through which they can effectively form dimers (9, 37, 38) . The different isoforms of SLMAP have been implicated in various functions from cell cycle and cell growth regulation (8) to myoblast fusion and muscle formation (9) . Further diversity in SLMAP isoforms and function is generated by alternative splicing mechanisms that result in SLMAP carrying one of two distinct C-terminal domains (TM1 and TM2), which target unique subcellular sites (1, 7-9, 37, 38) . We (7) have previously reported that TM2 can target SLMAP1 to the endoplasmic reticulum (ER) in COS-7 cells. Moreover, SLMAPs carrying either of the TM domains are highly expressed in myocardium and colocalize with caveolin 3 and L-type calcium channels (SL) as well as the calcium release channel (RyR2) of the SR (7) . Collectively, these initial findings are suggestive of a pivotal role for SLMAP in modulating cardiac electrophysiology and function.
The major aim of the present study was to assess whether SLMAP is an important structural component of the E-C coupling machinery and plays a role in cardiac electrophysiology and contractile function in vivo. To this end, we generated Tg mice with cardiac-restricted overexpression of the SLMAP1-TM2 sequence driven by ␣-myosin heavy chain (MHC) promoter. We reasoned that the overexpressed SLMAP1-TM2 protein would interfere with endogenous SLMAP homodimer formation and/or targeting. Our findings indicate that overexpression of SLMAP1-TM2 negatively impacts heart function by inducing structural and functional changes in the SR membrane, which are consistent with the observed dysfunction and catecholamine-induced cardiac alternans in Tg mice. These data further support a role for SLMAP in the membrane biology of cardiac function and that regulated levels of the protein are critical for E-C coupling. Transgenic animals were generated by cardiac-targeted expression of SLMAP sequences encompassing the LZ region and the transmembrane domain 2 (SLMAP1-TM2); TM2 targets SLMAP1 to ER membranes (5). SLMAP1 cDNA was tagged with a 6-myc repeat epitope in pcDNA3 vector (Invitrogen, Burlington, ON, Canada) as previously described (11, 37, 38) . The construct was in framed with ␣-MHC promoter originally subcloned into PBS2 SKϩ plasmid (Fig. 1A) . The complete transgene ␣-MHC-6-myc-SLMAP1-TM2 was released and microinjected into mice oocytes. B6C3F1 mice bearing the transgene were identified by PCR analysis of genomic DNA using a forward primer: 5=-GAA AAG CCT ATC GAA ATC AAG TTG-3= corresponding to exon 18 sequence, and reverse primer: 5=-ACC TTC  TTA AGC TCT TCT TGC AAA G-3= corresponding to exon 19. The  PCR amplicons were 244 bp for the coding cDNA of Tg SLMAP1-TM2 and 930 bp (686 bp of intron 18 plus 244 bp of exons 18 and 19) for the wild-type (WT) genomic DNA (37, 38) . Progeny were screened using PCR and Tg mice expressing SLMAP1-TM2 at low, moderate, and high levels (ranging from 1-to ϳ6-to ϳ15-fold respectively) compared with the endogenous ϳ34-kDa isoform were characterized. To reduce sex-related differences in cardiac phenotypes, only female age-matched littermates were considered for this study and were referred as to Tg mice.
METHODS

Generation of
In vivo monitoring of cardiac function using echocardiography, electrocardiography, and left ventricular pressure measurement. Age-matched littermates from Tg and WT animals were lightly anesthetized with 2% isoflurane. Transthoracic echocardiography was performed to obtain two-dimensional targeted M-mode recording using a 9-MHz ultrasound probe (VEVO700). Left ventricular (LV) pressures were monitored using Millar catheters, and electrocardiography (ECG) was used to measure electrical activity. Recordings were done at baseline and after intraperitoneal injection of a single bolus of isoproterenol (ISO; 0.01 mg/ml, 10 l/g of body weight). Three consecutive RR, PR, QRS, and QT intervals were signal averaged, and the QT interval was corrected for the length using the formula of Mitchell et al. (23) .
Chemicals and antibodies. All chemicals were purchased from Sigma-Aldrich (Saint Louis, MO). Antibodies used were directed against the following: cardiac RyR2, Serca2a, dihydropyridine receptor (DHPR) ␣ 2-subunit, CSQ, phospholamban (ABR), phospho-phospholamban (Badrilla, Leeds, UK), triadin (Santa Cruz Biotechnology, Santa Cruz, CA), calnexin (Stressgen, Victoria, BC, Canada), SLMAP (Abnova, Walnut, CA), GAPDH (Advanced ImmunoChemical), myc (Roche, Basel, Switzerland), ␤-adrenergic receptor (Abcam), and calreticulin (Pierce Thermo Scientific).
Protein extraction and Western blot. Cardiac tissues were homogenized in RIPA, and proteins were solubilized and cleared by centrifugation (10,000 g, 5 min, 4°C). Total proteins (20 ug) were size fractioned on a 5-15% polyacrylamide gradient gel and probed with the appropriate antibodies. Densitometry of protein bands was performed using AlphaEaseFC Analysis software (Alpha Innotech, San Leandro, CA).
Immunoprecipitation assay. Immunoprecipitation was carried out with anti-myc antibody using proteins from WT and Tg hearts. Proteins were solubilized in RIPA buffer and incubated with agarose beads coupled to anti-myc (Sigma) overnight at 4°C. Beads were collected by centrifugation (1 min, 2,000 rpm) and washed, and the protein complex was eluted (50 l of 5ϫ SDS buffer) by boiling for 5 min. Proteins were separated on 5-15% polyacrylamide gel and blotted with anti-myc and anti-SLMAP antibodies.
Subcellular fractionation, SR vesicles, and calcium transport. Hearts from 5-wk-old mice were homogenized in buffer (20 mTris pH 7.8, 30 mM histidine, and 0.6 M KCl) and centrifuged for 10 min at 1,600 g. The pellets were resuspended in the same buffer, and the centrifugation step was repeated. The supernatant from the centrifugation steps was pooled and recentrifuged at 14,000 g for 15 min, and the supernatant was further centrifuged at 45,000 g for 1 h. The pellets were collected and resuspended in a buffer containing 20 mM Tris pH 7.4, 30 mM histidine, and 250 mM sucrose and centrifuged for 1 h at 48,000 g. The pellet from this step was resuspended in the same buffer but pH 7.2 and referred to as the microsomes (or SR as indicated in Ref. 31 ), which were used in Western blot analysis and calcium transport studies. For calcium uptake measurement from 5-wk-old WT mice (n ϭ 12), and 5-wk-old Tg mice (n ϭ 12) animals were killed and cardiac microsomes were resuspended in uptake buffer containing the following (in mM): 100 KCl, 20 MOPS (pH 7.0), 5 oxalate, 5 MgCl2, 0.5 EGTA, 0.4 CaCl2, and 1 Ci of 45 Ca. The assay was initiated by addition of 5 mM of freshly prepared ATP and terminated after 10 min by being washed with 10 ml of distilled water using Millipore filters. Filter discs were left to dry and transferred to liquid scintillation cocktail (5 ml). Specific activity of 45 Ca was counted using a Wallac scintillation counter, and the specific amount of 45 Ca uptake was normalized to the amount of SR proteins. Quantitative real-time PCR. RNA was extracted from LV tissue from age-matched Tg and WT littermates and used as a template to generate cDNA using SuperScript II reverse transcription protocol following the manufacturer's guidelines (Invitrogen). Equal amounts of cDNA was utilized in real-time PCR using primers for mouse atrial natriuretic factor (ANF; forward 5=-GGGGGTAGGATTGACAG-GAT-3=, reverse 5=-CAGAGTGGGAGAGGCAAGAC-3=), ␤-MHC (forward 5=-CTCCCAAGGAGAGACGACTG-3=, reverse 5=-CCCT-TGGTGACGTACTCGTT-3=), and ribosomal RNA 18S (forward 5=-AATACATGCCGACGGGCGCT-3=, reverse 5=-AGTGGGTA-ATTTGCGCGCCT-3=) and fold induction was calculated using the ⌬⌬Ct method.
Histological analysis, immunofluorescence, and confocal and electron microscopy. Tissue preparation for histological examination, immunostaining, and confocal microscopy (Zeiss) was performed as previously described (2) . Electron microscopy was performed on thin sections of fixed myocardium using Jeol 1230 TEM and AMT software as previously described (24) .
Statistical analysis. Statistical analysis was performed using Graphpad Prizm version 5.0 (GraphPad Software, La Jolla, CA). A Student's t-test was applied, and values are presented as histograms of the means Ϯ SE of the percentage of protein expression of n independent experiments. For occurrence of alternans following ISO injection, a Fisher's test was performed. P Ͻ 0.05 was considered significant for all statistical analysis.
RESULTS
Characterization of Tg mice with cardiac-restricted expression of the SLMAP1-TM2.
The SLMAP gene is highly expressed in myocardium and undergoes extensive alternative splicing to generate several isoforms. SLMAP contains two leucine-enriched (LZ) coiled-coil regions that result in homodimerization of the protein and unique alternatively spliced C-terminal TM domains that target distinct subcellular membranes. We generated a SLMAP1 construct encompassing the LZ regions and C-terminal transmembrane anchor 2 (TM2) tagged with 6-myc in frame with ␣-MHC promoter to drive expression in mice myocardium (Fig. 1A ). Progeny were screened using PCR and Tg mice expressing SLMAP1-TM2 at low, moderate, and high levels were identified based on the endogenous expression of the 34-kDa SLMAP1. Western blot analysis with anti-SLMAP and anti-Myc of tissue samples from Tg mice showed that the ␣-MHC promoter drove the expression of ϳ50-kDa 6-myc-SLMAP1-TM2 protein in cardiac tissues. There was no notable appearance in the lung, liver, brain, or skeletal muscle (Fig. 1B, top) . The presence of the endogenous ϳ34-kDa SLMAP1 isoform expressed in cardiac and skeletal muscle in these mice is also shown for comparison (Fig. 1B, bottom) . The expression of SLMAP1-TM2 in the heart was followed up to 28 wk of age, and Fig. 1C reveals consistent expression of the transgene (probed with anti-myc) at 3, 5, and 28 wk of age. Western blot analysis of cardiac tissue from Tg mice showed that SLMAP1-TM2 exists in high molecular mass complexes ranging in size from ϳ128 kDa (doublet) and ϳ250 kDa when assessed with anti-SLMAP and anti-myc ( Fig. 2A) . To examine whether SLMAP1-TM2 can assemble with the endogenous SLMAP isoforms via homodimerization, immunoprecipitation of cardiac extracts from Tg mice with anti-myc was performed followed by Western blot analysis with either anti-myc (Fig. 2B, lane 1) or anti-SLMAP (Fig. 2B, lane 2) . Immunoblotting with anti-myc identified the presence of proteins of ϳ50, ϳ128, and 250 kDa (lane 1) while anti-SLMAP blotting also showed that the endogenous 34, ϳ83, and ϳ93 kDa SLMAP isoforms in cardiac extracts (lane 3) were coimmunoprecipitated together with SLMAP1-TM2 by anti-myc (lane 2).
Cardiac remodeling in SLMAP1-TM2 Tg mice. SLMAP1-TM2 Tg mice did not exhibit any obvious abnormalities and appeared normal up to 12 mo of age. Heart weight-to-body weight ratio was unchanged in young and adult animals relative to WT indicating absence of cardiac hypertrophy in these Tg mice (Fig. 3A) . Gross histological analysis of longitudinal section of cardiac tissue from Tg mice did not reveal any differences in cardiac size or chamber structure (atria and ventricles) compared with WT littermates (Fig. 3B) . At higher magnification irregular membrane enclosed vacuoles were noted in LV tissue of Tg mice (Fig. 3B) . These vacuoles were also noted in atria and the intraventricular septa (not shown). The extent of this membrane remodeling correlated with the level of expression of SLMAP1-TM2. The low expressers showed minor vacuolization that was more apparent upon higher magnification (data not shown). The vacuolization in the moderate and high overexpressers was apparent at low magnification (the severity of which correlated with the expression level of SLMAP1-TM2; Fig. 3C ). The high-expressing Tg lines were used for further experimentation. Failure of periodic acid Schiff to stain the vacuoles negated the possibility of developed glycogen storage disease as a result of SLMAP1-TM2 overexpression (data not shown). In view of the structural changes found in hearts from 5-wk-old Tg mice, we assessed the mRNA levels of cardiac fetal genes such as ANF and ␤-MHC using quantitative PCR. There was a marked increase in the levels (6-to 7-fold) of ANF and ␤-MHC mRNA in the SLMAP1-TM2 expressing Tg lines compared with WT indicating the presence of pathological remodeling (Fig. 3D) . 
SLMAP1-TM2 targets and impacts the SR/ER membranes in
Tg hearts. The TM2 tail anchor in SLMAP can target the ER in COS cells (1, 7). Thus we assessed whether the noted changes in the myocardium of SLMAP1-TM2 mice involve derangements of subcellular structures using transmission electron microscopy and confocal microscopy. At the ultrastructural level (transmission electron microscopy), Tg cardiomyocytes contained large membrane vacuoles that distorted the overall morphology of the cell (Fig. 4A ) in higher SLMAP1-TM2 expressers. Both the mitochondria and myofilaments appeared displaced due to the increased presence and size of the membrane vacuoles. These membrane vacuoles were also noted in the Tg hearts from the moderate expressers although they were fewer in number and appeared smaller in size. The ultrastructural changes were indicative of progressive SR membrane expansion correlating with increased expression of SLMAP1-TM2 (Fig. 4A) . Further, immunostaining of sectioned myocardium indicated that the SLMAP1-TM2 protein was colocalized with calnexin (ER/SR marker) in Tg myocytes (Fig. 4B, merged) . Moreover, the SLMAP1-TM2 protein was found along side with calnexin in membrane preparations from Tg myocardium (Fig. 4C) .
SLMAP1-TM2 expression impaired contractility and relaxation in Tg mice. Tg mice expressing high levels of SLMAP1-TM2 were assessed for cardiac function in vivo using transthoracic echocardiography (Table 1 ). The diastolic volume index (P Ͻ 0.05) and the stroke volume (P Ͻ 0.05) were less in Tg mice resulting in lower cardiac output (P Ͻ 0.01). Surprisingly, Tg mice did not show significant changes in contractility compared with WT animals at 5 wk of age (Table 2) . However, when mice were assessed at 28 wk there was evidence of reduced LV systolic pressure relative to agematched WT littermates (P Ͻ 0.001). Although increased levels of SLMAP1-TM2 did not affect the LV end diastolic pressure, the absolute values of both the developed (dP/ Values are means Ϯ SE. SLMAP1-TM2, sarcolemmal membrane-associated protein 1-transmembrane domain 2; WT, wild type; Tg, transgenic; Dd and Ds, diastolic and systolic diameters of left ventricle in mm; Vsi, systolic volume index corrected to body weight (BW) in l; Vdi, diastolic volume index corrected to BW in l; SVi, stroke volume index corrected to BW in l; EF, ejection fraction; Ci, cardiac index corrected to BW; HR, heart rate. dt max ) and declined (dP/dt min ) pressure of the LV were lower (P Ͻ 0.05) in Tg hearts (Table 2 ). These data suggest that overexpression of SLMAP1-TM2 can result in progressive deterioration of cardiac contractility through adulthood (from 5 to 28 wk).
SLMAP1-TM2 prolonged the QT interval in Tg mice. ECG tracings showed no changes in the heart rate (RR interval) or in the conductivity (PR interval and QRS segment duration) of Tg hearts at 5 wk of age. However, the corrected QT interval (QTc) was prolonged (ϳ15%) in SLMAP1-TM2 hearts compared with age-matched WT littermates (40.9 vs. 47.1 ms in WT vs. Tg at 5 wk of age, and 43.6 vs. 49.9 ms WT vs. Tg at 28 wk of age). The prolongation of QTc interval may be indicative of defective calcium recycling in Tg hearts (28 -30) . Similar ECG abnormalities were noted in 28-wk-old mice.
Stress-induced alternans and compromised cardiac performance of SLMAP1-TM2 Tg mice.
The development of progressive cardiac dysfunction through adulthood (from 5 to 28 wk) suggested that SLMAP1-TM2 hearts may be more prone to stress-induced abnormal cardiac function at early stages (5 wk of age). Thus we challenged the hearts with the ␤-adrenergic receptor agonist ISO, and both ECG and LV pressure were evaluated. ECG analysis revealed a similar increase in heart rate in both WT and Tg mice within 1 min of intraperitoneally administered ISO (P Ͼ 0.05). Interestingly, the development of pulsus alternans was noted in 8 out of 11 Tg mice after 10 min following ISO treatment (Fig. 5A) while none of the WT littermates showed irregularities in ECG recording (P Ͻ 0.05, Fisher's test). There was no change in the QTc interval 10 min post-ISO injection in Tg and WT mice. LV pressure recordings also showed alternans in pressure waves in response to ISO; eight out of nine Tg hearts compared with two out of nine WT (P Ͻ 0.05, Fisher test). Further, LV pressure measurements indicated that, in response to ISO, dP/dt max increased (P Ͻ 0.05) in WT (6,915 Ϯ 795 vs. 9,093 Ϯ 671 mmHg/s, baseline vs. ISO, respectively), whereas dP/dt min remained unchanged (6,466 Ϯ 606 vs. 6,357 Ϯ 487 mmHg/s, baseline vs. ISO, respectively; P ϭ 0.76). However, ISO failed to increase cardiac contractility (increase in ⌬dP/dt max 702 Ϯ 306 mmHg/s; P Ͻ 0.05) in Tg hearts to (2,177 Ϯ 618 mmHg/s) in the WT (Fig. 5, B and C) , although these hearts exhibited normal LV pressure at 5 wk of age. Collectively, these observations indicate that SLMAP1-TM2 results in progressive deterioration of cardiac function through adulthood with a hidden impairment of LV function at 5 wk that is unmasked under stress conditions.
SLMAP1-TM2 impacts the expression of proteins involved in calcium cycling and uptake in SR.
Western blot analysis of microsomes isolated from hearts of 5-wk-old Tg mice indicated that there was a dramatic decrease in the expression of the SR calcium handling proteins. While the loss of RyR2 was Values are means Ϯ SE of n animals. LVEDP, left ventricle end diastolic pressure; LVPSP, left ventricle peak systolic pressure; LVdP/dtmax and LVdP/ dtmin, maximal rate of left ventricle pressure development and decline, respectively. The differences in heart rate values with those reported in Table 1 (echocardiography) may be due to the surgical stress on the mice. modest, Serca2a, CSQ, and triadin expression was dramatically reduced in Tg hearts. Further, no apparent change in expression of caveolin 3 or the ␣ 2 -subunit of the DHPR (components of the SL/T tubules) was noted in the Tg hearts (Fig. 6A ). These observations indicated that SLMAP1-TM2 specifically impacts the expression level of SR proteins involved in calcium handling. To further assess for dysfunctional Ca 2ϩ handling, we evaluated the calcium uptake in cardiac SR vesicles of young 5-wk-old mice. Stimulation of SR Serca2a (using ATP) in Tg SR vesicles was associated with lower Ca 2ϩ uptake (ϳ50%) compared with WT vesicles (Fig. 6B ). There were no changes in the expression level or phosphorylation status of the Serca2a regulatory protein phospholamban when compared with WT animals (Fig. 6B) , indicating that reduced calcium uptake is directly linked to decreased expression level of Serca2a protein at SR membranes. Further, Western blot analysis also indicated that calreticulin, ␤-adrenergic receptor protein, or actin levels did not change in Tg myocardium (data not shown).
DISCUSSION
Herein we establish an in vivo role for the membrane protein SLMAP as a novel regulator of cardiac membrane biology and function. Specifically, cardiac-targeted overexpression of SLMAP1-TM2 protein resulted in significant alterations of 1) the structure of SR membranes, decreased expression of calcium cycling proteins, and defective Ca 2ϩ uptake; 2) cardiac contractility and relaxation; and 3) electrical activity and sensitization of the heart to catecholamines as evidenced by the induction of pulsus alternans.
Previous reports indicate that structural arrangement of T tubules and junctional SR (jSR) are controlled by jSR proteins. For example triadin, JPs, and CSQ of the SR, have been shown to play a pivotal role in the assembly of SL/SR junctions. Interestingly, either deletion or overexpression of SR proteins (i.e., triadin, JPs, and CSQ) can induce phenotypic alterations in SL/SR junctions (16, 17, 32-34, 36, 41) . This suggests that SR ultrastructure is highly sensitive to any imbalance in the expression of SR proteins. Our (7) previous findings indicated that SLMAP1-TM2 can target the ER in COS-7 and thus may play an important role in ER membrane biology. Herein, the in vivo studies also support the notion that SLMAP1-TM2 can target and operate at the level of SR/ER membranes of the mouse myocardium. Moreover, our data indicated that SLMAP1-TM2 overexpression results in dilation of the SR/ER membrane with a selective decrease in the SR proteins such as the RyR2, Serca2a, CSQ, and triadin while PLB and calreticulin levels remained unchanged. The DHPR and caveolin 3, components of the SL/T tubles, also remained unchanged in Tg hearts as was the case for the ␤-receptor.
Cardiac remodeling refers to changes in structure leading to myocardial dysfunction, and it is well established that this remodeling is associated with activation of fetal genes such as ANF and ␤-MHC as well as cardiac hypertrophy. Expression of SLMAP1-TM2 was associated with the dilation of the SR and activation of remodeling genes (ANF and ␤-MHC) but without the presence of hypertrophy. These data suggest that SR/ER stress is likely coupled to the activation of genes involved in cardiac remodeling and the fetal gene program (5, 40) . It appears that the expressed SLMAP1-TM2 interacts with endogenous SLMAP isoforms to form homodimers/oligomers that impact molecular remodeling, implying an important role for the regulated expression of endogenous SLMAP in normal membrane and cardiac biology. While the molecular mechanism of how SLMAP1-TM2 leads to changes in the SR/ER remains to be fully explored, its increased targeting may lead to activation of the unfolded protein response with the degradation of selective structural components of the membrane in Tg myocardium.
The SR plays a pivotal role in regulating cardiac function by regulating calcium cycling on a beat-to-beat basis. In the present study, overexpression of SLMAP1-TM2 had a negative impact on cardiac electrophysiology and contractile properties. Interestingly, the electrophysiological and contractile dysfunctions were age dependent. At 5 wk, the elongation of QT c interval was associated with normal contractility and minimal depression in cardiac output. However, at 28 wk Tg mice overtly exhibited compromised contractility and relaxation associated with prolonged QTc interval. These findings suggest a progressive deterioration of cardiac function through adulthood in the Tg mice. It is surprising that in view of the structural alterations noted in 5-wk-old Tg mice they have relatively normal cardiac function as indicated by ECG and LV assessment. There are several possible explanations for these findings. The young heart can more readily accommodate overexpressed SLMAP1-TM2 than the old heart. Normal expression pattern of endogenous SLMAP1 showed higher levels in young vs. old hearts (data not shown). Thus it could be that the younger Tg myocardium can tolerate overexpression of SLMAP1-TM2 (without loss of function) to a greater extent than older hearts. Alternatively, the young hearts may tolerate structural alteration (without loss of function) to a greater extent than older hearts. For example, Gould et al. (6) demonstrated that the young myocardium responded to coronary artery ligation with larger infarct area compared with older myocardium. However, cardiac dysfunction and mortality were more pronounced in older than younger animals (6) .
Although at 5 wk of age Tg mice showed normal contractility, silent dysfunctional myocardium was revealed by failure of ISO to improve cardiac performance (⌬dP/dt max ) as well as by the development of LV pressure alternans. The expression levels of the ␤-adrenergic receptor were unchanged in Tg hearts (data not shown), suggesting that a dysfunctional E-C coupling mechanism may be operative at the level of the SR. Others (3, 12, 14) have reported that overexpression or ablation of SR proteins induces an adaptive alteration in expression of calcium-handling proteins. It is unclear whether overexpression of SLMAP1-TM2 per se, or its effect on other SR proteins, led to cardiac dysfunction. In support of the later possibility, studies (3, 16, 18, 22, 25) have shown that decreased expression of RyR2, Serca2a, CSQ, and triadin alter cardiac function. Although SLMAP1-TM2 exhibited dimerization in vivo and potentially impacted endogenous SLMAP, there did not appear to be any physical interaction between SLMAP1-TM2 and RyR2 or Serca2a (data not shown). Irrespective, it is most likely that, despite the drastic changes in SR volume and proteins, 5-wk-old Tg hearts were still able to meet the cardiovascular demand at rest but not under stressful conditions.
Although the compromised contractility and relaxation of the myocardium were not lethal, the pulsus alternans noted in ECG recordings following ISO challenge could constitute a life-threatening condition (18 -20) . Catecholaminergic polymorphism ventricular tachycardia is most likely caused by increased amounts of residual cytosolic calcium concentration (19, 20, 39) . Catecholaminergic polymorphism ventricular tachycardia recorded in Tg mice with altered levels of RyR, CSQ, triadin, or JP was constantly related to changes in calcium recycling ability of the SR that increased cytosolic calcium concentration during diastole (3, 4, 16, 18, 35) . Further, studies have shown that silencing Serca2a gene resulted in impairment of calcium homeostasis and cardiac function (25, 27) , while overexpression of Serca2a attenuated cardiac alternans (4, 13) . Our data clearly indicated that calcium cycling proteins including Serca2a were reduced in SLMAP1-TM2 hearts. This was paralleled by a marked reduction in the ability of SR to accumulate calcium as shown by the net (ϳ50%) decrease in calcium uptake. This latter observation suggests that the amount of calcium recycled on a beat-to-beat basis in Tg mice is significantly lower than WT animals thus potentially leading to pulsus alternans.
Collectively, our data show that expressed SLMAP1-TM2 can target SR membranes and interfere with endogenous SLMAP in vivo to induce changes exemplified by an increase of the SR volume and decreased expression of calcium cycling proteins. This resulted in cardiac remodeling and compromised cardiac electrophysiology and performance. We propose that SLMAP, similarly to other tail-anchored membrane proteins of the SR (i.e., JPs and triadin), may serve to organize subcellular membrane architecture (3, 7, 17, 32) and the data here suggest that SLMAP may indeed be critical for effective E-C coupling by impacting the molecular components of these membranes involved in regulating calcium dynamics. Thus appropriate levels of SLMAP proteins are critical for the normal membrane biology and function of the myocardium.
